版本:
中国

BRIEF-ClinicalTrials.gov says Janssen's study of niraparib suspends recruitment

June 9 ClinicalTrials.gov:

* Janssen Research's study of niraparib in men with metastatic castration-resistant prostate cancer, DNA-repair anomalies suspended recruitment

* Current participants in Janssen Research's study of niraparib remain active and on study treatment Source text - (bit.ly/2r2uR15)

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐